Clinical Trial Update: Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-responders [Phase 1, Phase 2]

View source ↗

Summary

An update on a clinical trial evaluating Triptolide Woldifii for modulating T cell activation and inflammation in HIV-infected immunological non-responders (Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Triptolide Woldifii (Triptolide)

Snippet

Sponsor: LI Taisheng | Conditions: HIV | Phase 1, Phase 2 | Status: UNKNOWN